↓ Skip to main content

PLOS

Recombinant VP1, an Akt Inhibitor, Suppresses Progression of Hepatocellular Carcinoma by Inducing Apoptosis and Modulation of CCL2 Production

Overview of attention for article published in PLOS ONE, August 2011
Altmetric Badge

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
20 Mendeley
Title
Recombinant VP1, an Akt Inhibitor, Suppresses Progression of Hepatocellular Carcinoma by Inducing Apoptosis and Modulation of CCL2 Production
Published in
PLOS ONE, August 2011
DOI 10.1371/journal.pone.0023317
Pubmed ID
Authors

Tai-An Chen, Jui-Ling Wang, Shao-Wen Hung, Chiao-Li Chu, Yung-Chih Cheng, Shu-Mei Liang

Abstract

The application of viral elements in tumor therapy is one facet of cancer research. Recombinant capsid protein VP1 (rVP1) of foot-and-mouth disease virus has previously been demonstrated to induce apoptosis in cancer cell lines. Here, we aim to further investigate its apoptotic mechanism and possible anti-metastatic effect in murine models of hepatocellular carcinoma (HCC), one of the most common human cancers worldwide.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 5%
Taiwan 1 5%
Unknown 18 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 30%
Student > Ph. D. Student 5 25%
Other 2 10%
Student > Doctoral Student 1 5%
Lecturer 1 5%
Other 1 5%
Unknown 4 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 30%
Medicine and Dentistry 5 25%
Veterinary Science and Veterinary Medicine 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Arts and Humanities 1 5%
Other 2 10%
Unknown 4 20%